STING1 and neoplasm: STING positivity of tumor cells was detectable in 8908 (58.1%) of the 15,345 analyzable tumors, including 4169 (27.2%) with weak, 2005 (13.1%) with moderate, and 2734 (17.8%) with strong immunostaining.